ACSL5-IN-2
ACSL5-IN-2 (Compound B) is an Acyl CoA synthetase 5 (ACSL5) inhibitor. ACSL5-IN-2 can block the conversion of long-chain fatty acids (such as palmitic acid and oleic acid) into acyl-CoA, and intervene in the fatty acid metabolism pathway. ACSL5-IN-2 can inhibit cancer cells growth. ACSL5-IN-2 can be used for the research of cancer and metabolic disease, such as colon cancer and dysfunction-associated Steatohepatitis[1].
Product Specifications
CAS Number
3098297-74-3
UNSPSC
12352005
Target
Drug Derivative
Related Pathways
Others
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cancer; Metabolic Disease
Purity
98.78
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
CC[C@@H](OC1=C(F)C(F)=C(C(NS(C2=CC=C(OCCN(C)C)C=C2)(=O)=O)=O)C=C1)C3=CC=C(OCC4CC4)C=N3
Molecular Formula
C29H33F2N3O6S
Molecular Weight
589.65
References & Citations
[1]Thomas Bernard LEVY, et al. Compounds and methods of their use. WO2025174957A1. 2025-02-13
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GAD1 / GAD67 (GABAergic Neuronal Marker) (GAD1/2563), CF740 conjugate, 0.1mg/mL
